Figure 1From: Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion Experimental design. Graph illustrating the experimental design including transient middle cerebral artery occlusion (tMCAO), metformin administration, infarct volume, protein expression and neurobehavioral assessments.Back to article page